The United Kingdom RUO immunoassay market is projected to grow at a CAGR of 10.57% from 2025 to 2030.
The UK RUO immunoassay market is expanding with a growing focus on personalized medicine and testing. To capitalize on the opportunity, in April 2023, Oxford Nanopore and bioMérieux entered into a strategic partnership to develop innovative infectious disease diagnostics. Their partnership is to develop a new generation of nanopore-based molecular sensing that will help for rapid and accurate identification of microbial pathogens and associated antimicrobial resistance. Similarly, ImmunoServ on August 2023, launched the Immuno-T™ Laboratory Test Kit, which enables standardized and scalable T-cell testing to be performed in laboratories.
Moreover, Elecsys Anti-HEV IgM and Elecsys Anti-HEV IgG immunoassays were launched by the Roche Group, in November 2023, for the detection of hepatitis E virus (HEV) infections and treatment. Further, Avacta Group plc announced it had acquired Coris Bioconcept SRL in June 2023, for a cash of £7.4 million.
The UK's RUO immunoassay market is witnessing a significant upswing due to the focus on personalized treatments in cases of cancer. The mortality by cancer is going up, from 148,359 in 2021 to 152,833 in 2022. There is a growing focus of the government and private players for cancer research and a trend towards high funding allocation.
These developments are also backed by science and tech businesses through investments in critical life science manufacturing projects worth £92 million to increase health resilience, this is part of the wider government plan. Two prominent pharmaceutical companies have committed a total investment of £84 million into their manufacturing sites in the UK and are set to receive additional funding from the government.
Almac, in Northern Ireland, focuses on producing medications for diseases like cancer and heart disease. Meanwhile, Ortho Clinical Diagnostics, located in Pencoed, Wales, is expanding its testing capabilities to aid in the identification of various conditions and diseases.
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Report Metric | Details |
| Growth Rate | CAGR of 10.57% |
| Study Period | 2020 to 2030 |
| Historical Data | 2020 to 2023 |
| Base Year | 2024 |
| Forecast Period | 2025 – 2030 |
| Forecast Unit (Value) | USD Billion |
| Segmentation |
|
| Geographical Segmentation | England, Scotland, Wales, Northern Ireland |
| List of Major Companies in the United Kingdom RUO Immunoassay Market | |
| Customization Scope | Free report customization with purchase |
United Kingdom RUO Immunoassay Market Segmentation
By Product Type
By Sample Type
By Application
By End-User
By State